LPA and chronic kidney disease: RAGE ligands (AGE, S100A8/A9, S100B, amyloid-beta, LPA, HMGB1, C1q, suPAR) and sRAGE are elevated in CKD, COVID-19 and many of the co-morbidities that increase the risk of disease severity.